Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study
Abstract Background The efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer has been demonstrated in phase III trials. However, as patients receiving eribulin in daily practice do not necessarily meet all the eligibility criteria of clinical trials, data for...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2017-12-01
|
| Serija: | BMC Cancer |
| Teme: | |
| Online pristup: | http://link.springer.com/article/10.1186/s12885-017-3846-8 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|